Journal of Current Glaucoma Practice

Register      Login

VOLUME 8 , ISSUE 1 ( January-April, 2014 ) > List of Articles


Comparison of Treated Mean Intraocular Pressure in Stable Glaucoma with Different Severity in Vietnam

Nguyen Thi Ha Thanh

Keywords : Intraocular pressure, Stable glaucoma, Stage, Medication

Citation Information : Ha Thanh NT. Comparison of Treated Mean Intraocular Pressure in Stable Glaucoma with Different Severity in Vietnam. J Curr Glaucoma Pract 2014; 8 (1):7-9.

DOI: 10.5005/jp-journals-10008-1153

License: CC BY-NC 4.0

Published Online: 01-04-2019

Copyright Statement:  Copyright © 2014; The Author(s).


Purpose: To compare stable glaucoma with different severity in a Vietnamese population in regard to mean intraocular pressure (IOP) and number of medications used. Materials and methods: A total of 116 eyes from 68 patients with medically treated glaucoma were prospectively enrolled at a single center and subjected to automated perimetry every 3 months for at least 9 months. Glaucoma progression was identifed according to early manifest glaucoma trial criterion using glaucoma progression analysis software. Eyes in which no progression was identifed were staged for glaucoma severity using field criteria (mild MD ≥ 6 dB, moderate MD –6 to –12 dB, advanced MD ≥ 12 dB, end-stage central island only). Groups were compared in terms of mean IOP and number of medications used. Statistical analysis was performed using SPSS v16.0. Results: A total of 109 eyes displayed no evidence of pro gres-sion during the study period. Pretreatment mean IOP for mild, moderate, severe and end-stage glaucoma was 28.2 ± 1.4, 28.8 ± 1.6, 29.1 ± 1.8, and 28.6 ± 0.8 mm Hg. The mean IOP of all 109 eyes during follow-up was 16.8 ± 1.4 mm Hg (95% conf dence interval = 15.4 ± 18.2 mm Hg). Mild, moderate, advan ced, and end-stage glaucoma had mean IOP of 17.5 ± 1.2, 16.9 ± 1.3, 15.8 ± 0.9 and 15.5 ± 1.1 mm Hg. The mean IOP of mild stage was significantly higher than advanced and end-stage (t-test, p < 0.001). Also, the mean IOP of moderate glaucoma was significantly higher than advanced and end-stage glaucoma (t-test, p < 0.05). Number of medications had no signi ficant difference among these glaucoma stages (chi-square test, p > 0.05). Conclusion: Reached IOP lowering contributes to glaucoma stabilization especially in late stages. To maintain stable glaucoma, there was no difference in medical procedure of glaucoma stages.

PDF Share
  1. European Glaucoma Society. Terminology and guidelines for glaucoma. 2nd ed. Savona, Italy: Dogma; 2003.
  2. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factor for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003 Jan;121(1):48-56.
  3. Carroll SC, Gaskin BJ, Goldberg I, Danesh-Meyer HV. Glaucoma prescribing trends in Australia and New Zealand. Clin Experiment Ophthalmol 2006 Apr;34(3):213-218.
  4. Heijl A, Leiske MC, Bengstton B, Hussein M; Early Manifest Glaucoma Trial Group. Measuring visual field progression in early manifest glaucoma trial. Acta Ophthalmol Scand 2003 Jun;81(3): 286-293.
  5. Nouri-Mahdavi K, Hoffman D, Gaasterland D, Caprioli J. Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci 2004 Dec;45(12):4346-4351.
  6. Chauhan BC, Garway-Heath DF, Goñi FJ, Rossetti L, Bengtsson B, Vishwanathan AC, Heiji A. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 2008 Apr;92(4):569-573.
  7. Shaarawy, TM.; Sherwood, MB.; Grehn F. Guidelines on design and reporting of glaucoma surgical trials. Amsterdam, The Netherlands: World Gluucoma Association, Kugler Publications; 2009.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.